Vertex Pharmaceuticals (VRTX) Inventory (2011 - 2026)

Vertex Pharmaceuticals' Inventory history runs 16 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Inventory rose 29.93% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 29.93% YoY), while the FY2025 annual figure was $1.7 billion, up 39.94% from the prior year.
• Inventory was $1.8 billion for Q1 2026 at Vertex Pharmaceuticals, up from $1.7 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.8 billion in Q1 2026 to a low of $338.9 million in Q1 2022.
• Historically, Inventory has averaged $945.5 million across 5 years, with a median of $813.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory gained 13.4% in 2022, then soared 77.41% in 2023.
• A 5-year view of Inventory shows it stood at $460.6 million in 2022, then surged by 60.4% to $738.8 million in 2023, then soared by 63.16% to $1.2 billion in 2024, then jumped by 39.94% to $1.7 billion in 2025, then advanced by 4.74% to $1.8 billion in 2026.
• The last three Inventory figures came in at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.